Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis

• मुख्य लेखकों: Pablo Bascuñana (लेखक), Luisa Möhle (लेखक), Mirjam Brackhan (लेखक), Jens Pahnke (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2020-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Fingolimod is an approved treatment for relapsing-remitting multiple sclerosis (MS), and its properties in different pathways have raised interest in therapy research for other neurodegenerative diseases. Fingolimod is an agonist of sphingosine-1-phosphate (S1P) receptors. Its main pharmaco...